Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres.

AIM One objective of Ophdiat, a telemedical network using digital non-mydriatic cameras in Ile-de-France, is to develop a comprehensive screening programme that provides access to annual fundus examinations to all diabetic patients. The aim of this study was to evaluate the benefits of this programme in a hospital setting. METHODS A retrospective analysis of 500 case reports of diabetic patients hospitalized before and after Ophdiat setup was performed in five reference hospital centres. At each centre, 100 case reports (50 before, 50 after) of patients aged greater than 18 years, hospitalized for their annual check-up, with no known diabetic retinopathy (DR) before hospitalization and with the last fundus examination performed greater than 11 months previously, were randomly selected. The primary endpoint was the proportion of patients whose fundus examinations were performed during hospitalization; secondary endpoints were the number of cases of DR found and the time taken by ophthalmologists to make the diagnosis. RESULTS The mean proportion of patients with fundus examinations was 50.4% and 72.4% before and after, respectively, Ophdiat (P<0.01). The prevalence of DR was 11.1% before and 12.7% after (not significant). The mean time taken by an ophthalmologist per diagnosis of DR was 0.90 half-day before and 0.32 half-day after Ophdiat. CONCLUSION This evaluation shows that Ophdiat, combined with the availability of modern and effective devices, has improved DR screening in diabetology departments in hospitals. Additional human resources would certainly ensure more effective use of the system.

[1]  J. Sahel,et al.  [Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM]. , 1996, Diabetes & metabolism.

[2]  A. Erginay,et al.  OPHDIAT: a telemedical network screening system for diabetic retinopathy in the Ile-de-France. , 2008, Diabetes & metabolism.

[3]  Présentation par Bernard Charbonnel Les recommandations de l’ANAES sur le suivi du patient diabétique de type 2 à l’exclusion du suivi des complications , 1999 .

[4]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[5]  A Erginay,et al.  OPHDIAT: quality-assurance programme plan and performance of the network. , 2008, Diabetes & metabolism.

[6]  F. Jónasson,et al.  Active prevention in diabetic eye disease. A 4-year follow-up. , 2009, Acta ophthalmologica Scandinavica.

[7]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[8]  J. Sahel,et al.  [Recommendations of the ALFEDIAM (French Association for the Study of Diabetes and Metabolic Diseases) for the screening and surveillance of diabetic retinopathy]. , 1997, Journal francais d'ophtalmologie.

[9]  E. Agardh,et al.  The Five‐year Incidence of Blindness after Introducing a Screening Programme for Early Detection of Treatable Diabetic Retinopathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[10]  Stephen J. Aldington,et al.  Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. , 1997, Ophthalmology.

[11]  R. Bourrel,et al.  Les modalités de suivi des diabétiques non insulino traités en France métropolitaine durant l'année 1998 , 2008 .

[12]  P. Scanlon,et al.  Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy , 2003, The British journal of ophthalmology.

[13]  Cécile Delcourt,et al.  Visual impairment in Type 2 diabetic patients , 1995 .

[14]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[15]  J. Fleiss Statistical methods for rates and proportions , 1974 .

[16]  H. Ahmadieh,et al.  Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Group. , 1988, Ophthalmology.